Freddy A. Jimenez - 05 Jun 2025 Form 4 Insider Report for Celldex Therapeutics, Inc. (CLDX)

Role
SVP & GENERAL COUNSEL
Signature
/s/ Sam Martin, attorney-in-fact for Freddy A. Jimenez
Issuer symbol
CLDX
Transactions as of
05 Jun 2025
Transactions value $
$0
Form type
4
Filing time
09 Jun 2025, 16:18:04 UTC
Previous filing
17 Jun 2024
Next filing
15 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jimenez Freddy A. SVP & GENERAL COUNSEL C/O CELLDEX THERAPEUTICS, INC., 53 FRONTAGE ROAD, SUITE 220, HAMPTON /s/ Sam Martin, attorney-in-fact for Freddy A. Jimenez 09 Jun 2025 0001838114

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLDX Incentive Stock Option (right to buy) Award $0 +75K $0.00 75K 05 Jun 2025 Common Stock 75K $19.53 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.
F2 25% vest on June 5, 2026 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.